Scientists have developed an algorithm that combines genome sequence data and electronic health information to predict risk for genetic disease.
John Farquhar, a beloved mentor, and pioneer in cardiovascular disease prevention at Stanford, died Aug. 22 at the age of 91.
For the past four years cardiologist Josh Knowles, MD, PhD, has been treating patients at Stanford who have a little-known but common genetic heart disease called …
Hypertrophic cardiomyopathy is caused by various genetic mutations that cause heart muscle to contract with too much force. New research suggests why.
A second-year medical student is part of a team designing personalized cardiac catheters.
A former Stanford biodesign innovation fellow describes how he and colleagues came to develop an inexpensive and simple tool to diagnose arrhythmias.
This Stars of Stanford Medicine Q&A features Andrew Chang, clinical instructor of medicine, who is working to improve cardiovascular health globally.
A new study shows that the process of turning a group of blood vessel cells into an artery actually requires that they stop growing.
Stanford researchers use gene editing and stem cell technologies to determine whether to worry — or not — about mysterious genetic test results.
At 91, Jack Farquhar reflects on the growth of the field of preventative health, his longevity, the importance of community and more.
Stanford heart doctors bank on digital health to improve heart care in the future by monitoring encouraging exercise, detecting and tracking conditions like atrial fibrillation, and more.
Physician Shreya Shah discusses the controversies, problems and solutions to improve care for patients with high blood pressure in the United States.
In this video, Stanford Medicine heart surgeon Joseph Woo discusses his award-winning research that examined the pros of cons of mechanical versus biological valve replacements.
In one of the largest observational studies on fitness and heart disease, researchers examined found that people with higher levels of grip strength, physical activity and cardiorespiratory fitness had reduced risks of heart attacks and stroke.
In 1968, the first successful adult heart transplant took place at Stanford. Here's what has happened since then.
Rheumatoid arthritis and coronary artery disease share a common culprit: an important type of immune cell, called a macrophage, that has gone haywire. Stanford investigators have zeroed in on a molecular defect in macrophages' metabolic process that drives both disorders.
